Bredeson C, Leger C, Couban S, Simpson D, Huebsch L, Walker I, Shore T, Howson-Jan K, Panzarella T, Messner H, Barnett M & Lipton J. An evaluation of the donor experience in the Canadian multicenter randomized trial of bone marrow versus peripheral blood allografting. Biol Blood Marrow Transplant 10:405-414, 2004.
Cournoyer D, Toffelmire EB, Wells GA, Barber DL, Barrett BJ, Delage R, Forrest DL, Gagnon RF, Harvey EA, Laneuville P, Patterson BJ, Poon MC, Posen GA, Messner HA; Canadian PRCA Focus Group. Anti-erythropoietin antibody-mediated pure red cell aplasia after treatment with recombinant erythropoietic products: recommendations for minimization of risk. J Am Soc Nephrol 15(10): 2728-34, 2004.
Elwood N, Jiang XR, Chiu CP, Lebkowski J & Smith C. Enhanced long term survival but no increased replicative capacity following retroviral transduction of cord blood CD34+ cells with hTERT. Hematologica 89: 377-378, 2004.
Gasparetto M, Sebti S, Bhalla K and Smith C. Identification of small molecules that enhance anti-CD20 mediated apoptosis and cell cycle effects in non-Hodgkin’s lymphoma cells using automated flow cytometric screening. J Immunologic Methods 292: 59-71, 2004.
Hogge DE, Feuring-Buske M, Gerhard B & Frankel AE. The efficacy of diphtheria-growth factor fusion proteins is enhanced by co-administration of cytosine arabinoside in an immunodeficient mouse model of human acute myeloid leukemia. Leuk Res 28: 1221-1226, 2004.
Khoury H, Dalal BI, Nantel SH, Horsman DE, Lavoie JC, Shepherd JD, Hogge DE, Toze CL, Song KW, Forrest DL, Sutheralnd HJ, Nevill TJ. Correlation between karyotype and quantitative immunophenotype in acute myelogenous leukemia with t(8;21). Mod Pathol 17(10): 1211-6, 2004.
Kuruvilla J, Forrest DL, Lavoie JC, Nantel SH, Shepherd JD, Song KW, Sutherland HJ, Toze CL, Hogge DE & Nevill TJ. Characteristics and outcome of patients developing endocarditis following hematopoietic stem cell transplantation. Bone Marrow Transplant 34(11): 969-973, 2004.
Leger CS, Nevill T. Hematopoietic stem cell transplantation: A primer for the primary care physician. Review article. Canadian Medical Association Journal 170:1569-1577, 2004.
Mollee P, Gupta V, Song K, Reddy V, Califaretti N, Tsang R, Crump M, Keating A. Long-term Outcome After Intensive Therapy with Etoposide, Melphalan, Total Body Irradiation and Autotransplant for Acute Myeloid Leukemia. Bone Marrow Transplantation 33(12): 1201-1208, 2004.
Nicolini FE, Cashman JD, Hogge DE, Humphries RK & Eaves CJ. NOD/SCID mice engineered to express human IL-3, GM-CSF and Steel Factor constitutively mobilize engrafted human progenitors and compromise human stem cell regeneration. Leukemia 18: 341-347, 2004.
Seftel MD, Growe GH, Petraszko T, Benny WB, Le A, Lee CY, Spinelli JJ, Sutherland HJ, Tsang P & Hogge DE. Universal prestorage leukoreduction in Canada decreases platelet alloimmunization and refractoriness. Blood 103(1):333-9, 2004.
Smith C. Stem Cells and Transplantation. Cancer Control 11:75-77, 2004.
Smith M, Barnett M, Bassan R, Gatta G, Tondini C, Kern W. Adult acute myeloid leukaemia. Crit Rev Oncol Hematol 50:197-222, 2004.
Song KW, Rifkind J, Al-Beirouti B, Yee K, McCrae J, Messner HA, Keating A & Lipton JH. Short Communication: Subdural hematomas during CML therapy with imatinib mesylate. Leukemia and Lymphoma 45(8): 1633-1636, 2004.
Toze CL, Barnett MJ, Connors JM, Gascoyne RD, Voss NJ, Nantel SH, Nevill TJ, Shepherd JD, Sutherland HJ, Lavoie JC, Forest DL,Song KW & Hogge DE. Long-term disease-free survival of patients with advanced follicular lymphoma after allogeneic bone marrow transplantation. Br J Haematol 127: 311-321, 2004.
Urieto JO, Liu T, Black JH, Cohen KA, Hall PD, Willingham MC, Pennell LK, Hogge DE, Kreitman RJ & Frankel AE. Expression and purification of the recombinant diphtheria fusion toxin DT388IL3 for phase I clinical trials. Protein Expr Purif 33: 123-133, 2004.
Vercauteren SM, Sutherland HJ. Constitutively active Notch4 promotes early human hematopoietic progenitor cell maintenance while inhibiting differentiation and causes lymphoid abnormalities in vivo. Blood 105(8): 2315-2322, 2004.
